128 related articles for article (PubMed ID: 1478015)
21. Nail changes after chemotherapy.
Las Heras G; Juncà Piera J
Haematologica; 1998 Aug; 83(8):748. PubMed ID: 9793260
[No Abstract] [Full Text] [Related]
22. PUVA-induced pigmented nails.
Weiss E; Sayegh-Carreño R
Int J Dermatol; 1989 Apr; 28(3):188-9. PubMed ID: 2486057
[No Abstract] [Full Text] [Related]
23. Longitudinal melanonychia associated with hydroxyurea therapy in a patient with essential thrombocytosis.
Cohen AD; Hallel-Halevy D; Hatskelzon L; Peretz E; Halevy S
J Eur Acad Dermatol Venereol; 1999 Sep; 13(2):137-9. PubMed ID: 10568495
[TBL] [Abstract][Full Text] [Related]
24. [Longitudinal melanonychia induced by hydroxyurea therapy].
Neynaber S; Wolff H; Plewig G; Wienecke R
J Dtsch Dermatol Ges; 2004 Jul; 2(7):588-91. PubMed ID: 16281621
[TBL] [Abstract][Full Text] [Related]
25. Melanonychia and mucocutaneous hyperpigmentation from hydroxyurea use for the treatment of essential thrombocytosis.
Karanth SS; Gupta A; Prabhu M
Singapore Med J; 2014 Jan; 55(1):e7-8. PubMed ID: 24452985
[TBL] [Abstract][Full Text] [Related]
26. Mucocutaneous lesions and nail pigmentation in a patient with essential thrombocytosis.
Calleja Algarra A; Miguel RA; Tous Romero F; Maroñas Jiménez L
Aust Fam Physician; 2017; 46(4):222-224. PubMed ID: 28376576
[No Abstract] [Full Text] [Related]
27. [Nail pigmentation caused by azidothymidine].
Depaoli MA; Bedello PG; Tamponi M
G Ital Dermatol Venereol; 1989 Mar; 124(3):71-2. PubMed ID: 2807386
[TBL] [Abstract][Full Text] [Related]
28. Cutaneous pigmentation after daunorubicin chemotherapy.
Anderson LL; Thomas DE; Berger TG; Vukelja SJ
J Am Acad Dermatol; 1992 Feb; 26(2 Pt 1):255-6. PubMed ID: 1552062
[No Abstract] [Full Text] [Related]
29. Nail pigmentation with daunorubicin therapy.
deMarinis M; Hendricks A; Stoltzner G
Ann Intern Med; 1978 Oct; 89(4):516-7. PubMed ID: 697234
[No Abstract] [Full Text] [Related]
30. [Nail pigmentation caused by antimalarials].
Pigrau C; Buti M; Janesca J; González A
Med Clin (Barc); 1983 Apr; 80(11):512. PubMed ID: 6865530
[No Abstract] [Full Text] [Related]
31. Cutaneous adverse reactions to hydroxyurea in patients with intermediate thalassemia.
Zargari O; Kimyai-Asadi A; Jafroodi M
Pediatr Dermatol; 2004; 21(6):633-5. PubMed ID: 15575845
[TBL] [Abstract][Full Text] [Related]
32. Nail discoloration occurring after 8 weeks of minocycline therapy.
Ban M; Kitajima Y
J Dermatol; 2007 Oct; 34(10):699-701. PubMed ID: 17908141
[TBL] [Abstract][Full Text] [Related]
33. [Multiple keratosis induced by hydroxyurea].
Grange F; Couilliet D; Audhuy B; Krzisch S; Schlecht P; Guillaume JC
Ann Dermatol Venereol; 1995; 122(1-2):16-8. PubMed ID: 7668775
[TBL] [Abstract][Full Text] [Related]
34. Nail pigmentation following timolol maleate therapy.
Feiler-Ofry V; Godel V; Lazar M
Ophthalmologica; 1981; 182(3):153-6. PubMed ID: 7267004
[No Abstract] [Full Text] [Related]
35. [Nail pigmentation during therapy with cyclophosphamide and doxorubicin].
Manigand G; Faux N; Dumas D; Taillandier J; Fixy P; Richerd F
Sem Hop; 1983 Jun; 59(24):1840-1. PubMed ID: 6136095
[TBL] [Abstract][Full Text] [Related]
36. Hydroxyurea hypersensitivity reaction.
Jacobs P; Wood L; Foster J
S Afr Med J; 1989 May; 75(10):506. PubMed ID: 2727836
[No Abstract] [Full Text] [Related]
37. Cyclophosphamide-induced nail pigmentation.
Srikant M; Van Veen J; Raithatha A; Reilly JT
Br J Haematol; 2002 Apr; 117(1):2. PubMed ID: 11918527
[No Abstract] [Full Text] [Related]
38. Development of nail pigmentation during zidovudine therapy.
Anders KH; Abele DC
J Am Acad Dermatol; 1989 Oct; 21(4 Pt 1):792-3. PubMed ID: 2808794
[No Abstract] [Full Text] [Related]
39. Nail and skin hyperpigmentation associated with hydroxyurea therapy for polycythemia vera.
Gropper CA; Don PC; Sadjadi MM
Int J Dermatol; 1993 Oct; 32(10):731-3. PubMed ID: 8225715
[No Abstract] [Full Text] [Related]
40. Pigmentation with doxorubicin therapy.
Orr LE; McKernan JF
Arch Dermatol; 1980 Mar; 116(3):273. PubMed ID: 6245620
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
